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ical trials, observational studies, systematic reviews and economic evaluations.
Studies that fulfilled the inclusion criteria were reviewed and data-extracted. The
synthesis was narrative. RESULTS:After discarding duplicates, 1528 citations were
screened, and 833 full papers were retrieved for consideration. Eight out of 145
studies were included, which focused in either diabetes or heart disease. From
these, 21 utility values were identified and included in the database. Most of the
excluded studies used SF-36 or EQ-5D, but only for descriptive purposes, and did
not calculate the utility index. CONCLUSIONS: Few studies were available provid-
ing utilities elicited from the Spanish population for prevalent diseases such as
diabetes or heart disease. As next steps, other diseases will be explored, searches
will be conducted in other databases, authors and experts will be contacted to
identify additional, relevant information, and included studies will be quality-as-
sessed. This ongoing review and the database of Spanish utilities will be useful for
researchers developing economic evaluations or requiring information on quality
of life derived from the Spanish population. The project will also allow us to iden-
tify data gaps for which further research is needed.
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OBJECTIVES: The content validity of an instrument depends not only on the con-
cepts embodied in the items but also on how the items are structured to elicit
responses from patients. This research explores the “grammar” of individual items
and how it varies across a number of instruments in selected disease areas. The
goal is to understand how such considerations affect consistency of content and to
classify items by concept.METHODS:The structure of each item is characterized as
an item stem with a core concept, with an implicit or explicit context (e.g., a dis-
ease), event (e.g. “felt frustrated or impatient”), and stimulus (e.g., “about your
symptom”), as well as the recall period and response options. Concepts are classi-
fied using the WHO International Classification of Functioning (ICF). Similarities
and differences across instruments within disease areas are analyzed. RESULTS:
We decomposed over 600 items in at least 23 instruments across 5 disease areas
and several generic instruments, capturing and classifying each aspect of the
structure of each item. Most physical function items could be matched with spe-
cific 3-4 digit ICF codes; most emotional function items could not be matched as
specifically. There was considerable variation across instruments regarding the
explicit statement of context as well as the presence of a stimulus. We observed at
least 8 different recall periods ranging from an implied present to “in the past year”
to “in 10 years” with distinct patterns by disease area. We observed at least 9 types
of response options, but the majority of items used 5-point scales. CONCLUSIONS:
There are some commonalities but little standardization in how items are struc-
tured, within or across diseases. Classification and comparison of items and eval-
uating comparative content validity is complicated by the variation in most aspects
of how the items are phrased.
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OBJECTIVES: Patients’ self-reporting of drug exposure is subject to memory errors
and varying degrees of bias. Utilisation of prescription records is often impaired by
non-compliance and use of over-the-counter (OTC) drugs. Our study compared
patient self-reports (PSR) to physician’s prescription reports (PPR) for: cardiovascu-
lar drugs (CVDs), allegedly used on a daily basis to treat chronic conditions; drugs
for musculoskeletal disorders (MSDs) used intermittently; and vaccines.
METHODS: The reference pool from the PGRx database consists of several net-
works of general practitioners. For every referent included, data was obtained for
all drugs used within the two years preceding the consultation date via: 1) a struc-
tured telephone interview assisted by a guide listing pathologies and packaged
visual display of drugs; 2) and physician’s prescriptions reports. Both PSR and PPR
measurements were obtained independently and blindly by investigators. Com-
parisons were made on exposure to CVDs, MSDs and vaccines, for different time-
windows up to 24 months prior to the index date. RESULTS: The concordance
between physician and patient reports was assessed on 2702 and 4152 patient-
physician pairs for CVDs and MSDs, respectively. Overall, agreement between PSR
and PPR for all classes of CVDs was excellent (kappa 0.83 [95% confidence interval
(CI): 0.81 – 0.85]). Agreement was substantial for drugs for osteoarthritis (kappa 
0.62 [0.55 – 0.68]), fair for non-aspirin NSAIDs (kappa 0.31 [0.26 – 0.36]) and low for
muscle relaxants and non-narcotic analgesics. Use of OTC drugs was associated
with greater disagreement (Odds ratio  2.2 [95% CI: 1.1 – 1.4]), but not age.
CONCLUSIONS:The PGRx standardised and systematic collection of drug exposure
directly from patients provided similar data to physician prescription records for
chronic drug exposure. Differences between PSR and PPR in estimating prevalence
for drugs used in MSDs varied by type of drug and time elapsed up to the index date.
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OBJECTIVES: Given that the number of preference-based instruments has been
growing over the past years, it is important to compare their performance. This
work seeks to compare the performance of the SF-6D and EQ-5D across four dis-
eases: asthma, COPD, cataracts and rheumatoid arthritis. METHODS: The overall
sample consists of 643 cases. The indexes are analysed by disease group to explore
the instruments’ ability to distinguish between socio-demographic groups. Ceiling
and floor effects are calculated for both instruments. The level of agreement be-
tween the instruments is analyzed using correlation coefficients. Paired samples
t-tests are used to identify differences between the indexes. Regression analyses
are used to explore the relationship between the indexes. The discriminative prop-
erties of both indexes are also compared using ROC curves. RESULTS: Mean values
were the same for both indexes (0.72). However in the analysis by disease the mean
EQ-5D index was 0.05 higher than the mean SF-6D index for asthma and COPD.
There was a strong correlation between both indexes (0.68). Similar results were
found by disease group. The agreement level between both instruments was higher
between similar dimensions. Both instruments showed a similar ability to distin-
guish between socio-demographic groups. There was a significant ceiling effect in
the EQ-5D. The results of the regression models indicate that the relationship is not
uniform between the two indexes. These results are supported by specific hypoth-
esis tests. The analysis of the area under the curves showed that the SF-6D is more
efficient in detecting differences between groups in almost all cases.
CONCLUSIONS: The SF-6D generates higher values in disease groups. The SF-6D
and the EQ-5D perform differently in each of the diseases studied. These results do
not allow looking for a global adjustment between both measures regardless of the
health state of the individual. These differences should be further investigated.
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OBJECTIVES: Roma people compose a vulnerable minority with poor health which
has been the subject of discrimination. The aim was to provide a valid estimate of
the health status of Roma people in Greece, by using the validated instrument of
the SF-36 questionnaire, which has been widely used in previous surveys of general
and clinical populations, and also to determine whether SF-36 is a valid and reliable
instrument in assessing self-assessed health status of Roma population
METHODS: The study was carried out in 2009 in two geographically dispersed
Roma settlements in Greece. A sample of 433 Roma people was face to face inter-
viewed. The survey included the SF-36, questions on socio-demographic and
health related characteristics, health service use and factors associated with ma-
terial deprivation. Construct validity was investigated with “known group” validity
testing and reliability with chronbach alpha coefficient. Statistical significance was
accepted at the 5% level. All statistical analyses were undertaken using SPSS v.17.
RESULTS: Roma responders are young with mean age of 33.5 years old. However
they rate their health very low with highest score in PF (66.1%) and the lowest score
in MH (41.5%). RP and RE scales had high ceiling and floor effects. Cronbach’s alpha
coefficient met the criterion (0.70) for all eight scales with two exceptions. SF-36
scale scores distinguished well, and in the expected manner, between groups of
respondents providing evidence of construct validity. Significant statistical differ-
ences in mean scores were observed in relation to demographic characteristics,
socio-economic status, existence of chronic disease, health services utilization and
variables related to material deprivation. CONCLUSIONS: The findings support the
validity and reliability of the SF-36 when used in assessing Roma’s health. On the
other hand, Roma experience social exclusion and deprivation which profoundly
affect their health. Tackling the poor health of Roma acquires certain public health
interventions and health promotion programs.
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OBJECTIVES: The objective of the current study was to compare the accuracy of
different methods to estimate health state utility values (HSUVs) for comorbid
health conditions. METHODS: Data collected during five rounds of the Welsh
Health Survey (n64,437) were used to generate mean SF-6D scores for cohorts
with specific health conditions. These data were then used to estimate mean SF-6D
scores for cohorts with comorbid health conditions. RESULTS: The mean SF-6D
scores for the subgroups with comorbidities ranged from 0.465 to 0.607. The min-
imum and additive methods overestimated and underestimated the majority of
actual SF-6D scores, had mean absolute errors (MAE) of 0.056 and 0.121 and just 15%
and 3% of estimated values were within the mimimum important difference (MID)
for the SF-6D (0.041) respectively. While the multiplicative method also tended to
underestimate the actual SF-6D scores (MAE 0.075) it performed better when esti-
mating scores below 0.50 and 47% of estimated values were within the MID. A
linear model obtained by mapping the disutilities associated with the mean SF-6D
scores for two subgroups with single conditions (plus the interaction between the
two) onto the mean SF-6D scores for subgroups with comorbidities gave the most
accurate results overall. The predicted SF-6D scores had a mean absolute error of
0.0191 and 88% of predicted SF-6D scores accurate to within the MID.
CONCLUSIONS: While in our data the linear model gave the most accurate results,
additional research is required to validate our results.
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